MT Newswires2d agoneutral
Eli Lilly, Hims & Hers Health Expand Patient Access to Zepbound, FoundayoNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Business Wire2d agoneutral
Lilly and Hims & Hers expand access to FDA-approved Lilly medicinesGuruFocus.com2d agoneutral
State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 4Pharmaceutical Technology3d agoneutral
Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinicInsider Monkey3d agoneutral
Eli Lilly and Company’s (LLY) GLP-1 Franchise Faces Growing Price CompetitionMT Newswires3d agoneutral
LifeMD to Directly Ship Eli Lilly's Self-Pay GLP-1 Medicines Across the US24/7 Wall St.3d agoneutral
Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for LillyGuruFocus.com3d agoneutral
What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Nov. 3Simply Wall St.3d agobullish
Eli Lilly (LLY) Wins Ad Changes On Weight Loss Drugs And Recasts Its PipelineGuruFocus.com3d agobullish
OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...